Cbdmd, Inc. current report, 23 April 2020

Business Context and Reporting Period

This Form 8-K Current Report was filed by cbdMD, Inc. on April 23, 2020, regarding the results of its 2020 Annual Meeting of Shareholders held on the same date. The company is incorporated in North Carolina and trades on the NYSE American under the symbols YCBD and YCBD PR A.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.

Material Changes and Voting Results

Of the 51,335,648 shares of common stock outstanding, 23,402,746 shares (45%) were represented at the meeting, constituting a quorum. All proposals were approved.

Proposal 1: Election of Directors

The following directors were elected to hold office until the 2021 annual meeting:

Director Name For Against Abstain
Martin A. Sumichrast 22,771,505 246,187 0
R. Scott Coffman 22,746,276 0 216,114
Bakari Sellers 21,299,834 0 1,717,858
Peter J. Ghiloni 21,990,723 0 1,026,969
Scott G. Stephen 22,722,516 0 295,176
William F. Raines, III 22,746,533 0 271,159

Proposal 2: Ratification of Auditors

Shareholders ratified the appointment of Cherry Bekaert LLP as the independent registered public accounting firm.

  • For: 23,243,621
  • Against: 51,692
  • Abstain: 107,433

Guidance, Outlook, and Risks

The filing text does not provide a clear value for financial guidance, management commentary on future outlook, specific risks, contingencies, or unusual items. The document serves solely to report the outcome of the shareholder vote.

Investor Verification Checklist

  • Verify the definitive proxy statement (Schedule 14A) filed on March 11, 2020, for detailed background on the director nominees and auditor ratification.
  • Confirm the total number of shares outstanding (51,335,648) and the quorum threshold met (45%).
  • Review the specific terms of office for the newly elected directors, noting the text states they serve until the 2021 annual meeting.
  • Check subsequent filings for financial performance data, as this 8-K contains no financial metrics.